Allergy Therapeutics PLC Stock
Your prediction
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | - | -1.786% | -13.386% | 61.765% | -5.983% | 131.579% | -50.450% |
| Beximco Pharmaceuticals Ltd. GDR | -9.470% | -14.563% | -14.563% | -1.786% | -1.786% | 8.374% | -55.779% |
| Eledon Pharmaceuticals Inc. | -3.850% | 2.459% | 9.649% | -14.384% | 95.313% | 11.607% | -71.264% |
| SELLAS Life Sciences Group Inc | -3.300% | -17.586% | -17.110% | 254.950% | 26.455% | 172.831% | -53.532% |
News
Should You Buy AT&T Stock Before April 22?
A big potential catalyst for any stock is always its quarterly earnings report, which can give investors a good indication of whether its business is on the right path or not. If a company posts
3 Recession-Proof Stocks to Buy Before the Next Market Crash
These are trying times for growth investors, so maybe it's a good time to be trying something different. You know those all-weather defensive stocks that many have been rotating into these days
Stock Market Today, March 19: AT&T Rises After Launch of AI-Powered Customer App
AT&T (NYSE:T), a provider of wireless and broadband services in the U.S, closed Thursday at $27.77, up 1.30%. The stock is rising after coverage of its new AI-heavy customer app and 2025 digital